Welsis (WLSS) Enterprise Value (2022 - 2023)
Welsis' quarterly Enterprise Value came in at -$1368.0 in Q4 2023, up 90.43% year-on-year from -$718.38 in Q4 2022, and up 86.09% quarter-over-quarter from -$9834.0 in Q3 2023.
Welsis has reported Enterprise Value for 2 years, with the latest figure at -$1368.0 in Q4 2023.
- For the quarter ending Q4 2023, Enterprise Value rose 90.43% year-over-year to -$1368.0; the trailing twelve-month figure through Dec 2023 stood at -$1368.0 (up 90.43% YoY), and the FY2023 full-year result was -$9834.0, up 47.42% from the prior year.
- Enterprise Value for Q4 2023 stood at -$1368.0, up from -$9834.0 in the prior quarter.
- The five-year high for Enterprise Value was -$963.0 in Q1 2023, with the low at -$18703.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | -6.56 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | -878.29 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -265.37 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -315.87 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -748.60 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | -158.93 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -539.85 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -366.68 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | -174.90 Mn |
| 10 | Welsis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1,368.00 |
| Sep 30, 2023 | -9,834.00 |
| Jun 30, 2023 | -5,202.00 |
| Mar 31, 2023 | -963.00 |
| Dec 31, 2022 | -14,292.00 |
| Sep 30, 2022 | -18,703.00 |
| Jun 30, 2022 | -1,640.00 |